344 related articles for article (PubMed ID: 32419327)
1. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients.
Schlegel N; Boerner K; Waschke J
Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327
[TBL] [Abstract][Full Text] [Related]
2. Desmoglein 2 regulates the intestinal epithelial barrier via p38 mitogen-activated protein kinase.
Ungewiß H; Vielmuth F; Suzuki ST; Maiser A; Harz H; Leonhardt H; Kugelmann D; Schlegel N; Waschke J
Sci Rep; 2017 Jul; 7(1):6329. PubMed ID: 28740231
[TBL] [Abstract][Full Text] [Related]
3. Loss of Desmoglein 2 Contributes to the Pathogenesis of Crohn's Disease.
Spindler V; Meir M; Vigh B; Flemming S; Hütz K; Germer CT; Waschke J; Schlegel N
Inflamm Bowel Dis; 2015 Oct; 21(10):2349-59. PubMed ID: 26115074
[TBL] [Abstract][Full Text] [Related]
4. Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity.
Schlegel N; Meir M; Heupel WM; Holthöfer B; Leube RE; Waschke J
Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G774-83. PubMed ID: 20224006
[TBL] [Abstract][Full Text] [Related]
5. Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury.
Gross A; Pack LAP; Schacht GM; Kant S; Ungewiss H; Meir M; Schlegel N; Preisinger C; Boor P; Guldiken N; Krusche CA; Sellge G; Trautwein C; Waschke J; Heuser A; Leube RE; Strnad P
Mucosal Immunol; 2018 Nov; 11(6):1630-1639. PubMed ID: 30115995
[TBL] [Abstract][Full Text] [Related]
6. Desmoglein2 Regulates Claudin2 Expression by Sequestering PI-3-Kinase in Intestinal Epithelial Cells.
Burkard N; Meir M; Kannapin F; Otto C; Petzke M; Germer CT; Waschke J; Schlegel N
Front Immunol; 2021; 12():756321. PubMed ID: 34659262
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 5 is essential for maintenance of barrier function in mouse colon.
Liu Y; Chidgey M; Yang VW; Bialkowska AB
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G478-G491. PubMed ID: 28864500
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease.
Meir M; Burkard N; Ungewiß H; Diefenbacher M; Flemming S; Kannapin F; Germer CT; Schweinlin M; Metzger M; Waschke J; Schlegel N
J Clin Invest; 2019 Jun; 129(7):2824-2840. PubMed ID: 31205031
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
[TBL] [Abstract][Full Text] [Related]
10. Talk about micromanaging! Role of microRNAs in intestinal barrier function.
Al-Sadi R; Engers J; Abdulqadir R
Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G170-G174. PubMed ID: 32658620
[TBL] [Abstract][Full Text] [Related]
11. Dsg2 via Src-mediated transactivation shapes EGFR signaling towards cell adhesion.
Ungewiß H; Rötzer V; Meir M; Fey C; Diefenbacher M; Schlegel N; Waschke J
Cell Mol Life Sci; 2018 Nov; 75(22):4251-4268. PubMed ID: 29980799
[TBL] [Abstract][Full Text] [Related]
12. Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease.
Cheng Y; Hall TR; Xu X; Yung I; Souza D; Zheng J; Schiele F; Hoffmann M; Mbow ML; Garnett JP; Li J
EBioMedicine; 2022 Jan; 75():103758. PubMed ID: 34933179
[TBL] [Abstract][Full Text] [Related]
13. Regulation of intestinal epithelial intercellular adhesion and barrier function by desmosomal cadherin desmocollin-2.
Raya-Sandino A; Luissint AC; Kusters DHM; Narayanan V; Flemming S; Garcia-Hernandez V; Godsel LM; Green KJ; Hagen SJ; Conway DE; Parkos CA; Nusrat A
Mol Biol Cell; 2021 Apr; 32(8):753-768. PubMed ID: 33596089
[TBL] [Abstract][Full Text] [Related]
14. Desmoglein 2 can undergo Ca
Fuchs M; Kugelmann D; Schlegel N; Vielmuth F; Waschke J
Biophys J; 2022 Apr; 121(7):1322-1335. PubMed ID: 35183520
[TBL] [Abstract][Full Text] [Related]
15. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
16. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis.
Ebert LM; Tan LY; Johan MZ; Min KK; Cockshell MP; Parham KA; Betterman KL; Szeto P; Boyle S; Silva L; Peng A; Zhang Y; Ruszkiewicz A; Zannettino AC; Gronthos S; Koblar S; Harvey NL; Lopez AF; Shackleton M; Bonder CS
Angiogenesis; 2016 Oct; 19(4):463-86. PubMed ID: 27338829
[TBL] [Abstract][Full Text] [Related]
17. Requirement of cellular prion protein for intestinal barrier function and mislocalization in patients with inflammatory bowel disease.
Petit CS; Barreau F; Besnier L; Gandille P; Riveau B; Chateau D; Roy M; Berrebi D; Svrcek M; Cardot P; Rousset M; Clair C; Thenet S
Gastroenterology; 2012 Jul; 143(1):122-32.e15. PubMed ID: 22446194
[TBL] [Abstract][Full Text] [Related]
18. Epithelial maturity influences EPEC-induced desmosomal alterations.
Roxas JL; Vedantam G; Viswanathan VK
Gut Microbes; 2019; 10(2):241-245. PubMed ID: 30183504
[TBL] [Abstract][Full Text] [Related]
19. Enteropathogenic
Roxas JL; Monasky RC; Roxas BAP; Agellon AB; Mansoor A; Kaper JB; Vedantam G; Viswanathan VK
Cell Mol Gastroenterol Hepatol; 2018; 6(2):163-180. PubMed ID: 30003123
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
Hering NA; Schulzke JD
Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
